Prognostic Variables Associated With Improved Outcomes in Patients With Stage III NSCLC Treated With Chemoradiation Followed by Consolidation Pembrolizumab: A Subset Analysis of a Phase II Study From the Hoosier Cancer Research Network LUN 14-179

Publication | Open Access

DOI Full Paper Access

Citations

References

2019

Year

Bilal Anouti, Sandra K. Althouse, Greg Andrew Durm, Nasser H. Hanna

Clinical Lung Cancer

MedicineCancer ManagementImproved OutcomesSubset AnalysisCancer TreatmentConsolidation PembrolizumabOncologyRadiation OncologyLung CancerRadiologyHealth Sciences